RRS has educated & promoted research in the field of radiation sciences for over 60 years.
Captain Christopher Cassidy, NASA Astronaut, details his time in space in an exclusive interview with the Radiation Research Society. From launch to landing, perks and perils, Captain Cassidy shares all!
A 2017 interview with Dr. Charlie Maitz with the University of Missouri, School of Medicine and College of Veterinary Medicine shares how he found himself in veterinary radiation oncology, his recent work and the role the Radiation Research Society has played in his career.
A 2016 interview with Iris Eke. She began her career in medical school and moved to basic science after completing her thesis in radiation. Now a post-doc at NCI, Dr. Eke's primary focus is radiation therapy-induced targets.
A 2016 Inteview with Dr. Olga Martin, radiation biologist at Peter MacCallum Cancer Center. She has a long history in radiation research. Beginning in basic science, Dr. Martin has transitioned to applicable uses. Watch to learn how she uses her past research in her present work, as well as projects she is currently working on.
A 2016 interview with Jai Smith, of Peter MacCallum Cancer Center. He discusses his project in DNA binding to create a compound to aid in the protection of normal tissue in head and neck cancers.
A 2016 interview with Radia Tamarat, PhD, of the Institute of Radioprotection and Nuclear Safety. she discusses her research of the use of stem cell therapy to treat patients after normal tissue damage due to radiation exposure.
A 2016 interview with Maureen Aliru, MD-PhD student at MD Anderson. She shares her project from Sunil Krishnan's lab. The project uses gold nanoparticles, a known radiosensitizer, in the cell's nucleus. The lab hopes to use the information to help determine better decisions concerning radiation and dose.
A 2016 interview with Stephen McMahon, PhD, of Queen's University Belfast, discusses his work in predicting radiation sensitivity from phenotypic characteristics. His lab, with the goal of building better models, focuses primarily on DNA damage and repair.
An 2016 interview with Sijumon Kunjacha, PhD, of the Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School discusses his study of a dual-targeting strategy to specifically amplify damage in the tumor neoendothelium. The resulting tumor vascular disruption substantially improved the therapeutic outcome than targeting the cells alone
A 2016 inteview with Christin Glowa from the German Cancer discussing the unique aspects of her research and facility, and how it applies clinically.
